(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
Aston Martin Lagonda Global Holdings PLC - Gaydon, England-based luxury sports car manufacturer - Chief Executive Lawrence Stroll increases stake to 26% from 23% on October 3.
----------
Edinburgh Investment Trust PLC - Edinburgh-based investment trust - Liontrust Fund Partners LLP informs company that James de Uphaugh, the company's portfolio manager, will retire in February 2024. De Uphaugh will continue to manage the portfolio until February and will then be replaced as by Imran Sattar. As part of the succession, Sattar has been appointed deputy portfolio manager, replacing Chris Field who is due to retire from Liontrust in November. Other than the change of portfolio manager, there will be no change to the two investment objectives, strategy or the portfolio's key features, company says.
----------
DWF Group PLC - Manchester, England-based legal business with operations in North America - Announces the scheme which facilitates the bid by Inflexion Private Equity Partners LLP has become effective. The entire issued share capital of DWF is now owned or controlled by Inflexion. Shares in DWF have been suspended and are expected to be cancelled on October 4. As a result of the scheme becoming effective, DWF announces that: Teresa Colaianni, Samantha Duncan, Luke Savage, Jonathan Bloomer and Chris Sullivan have resigned as non-executive directors with effect from October 3. Further, Seema Bains and Michele Cicchetti have resigned as partner directors of the board with effect from October 3.
----------
Angus Energy PLC - UK-focused oil and gas development company - Reports gas volumes produced and sold from the Saltfleetby Field equalled 7.9 million therms in aggregate for the months of July, August and September, compared to 6.8 million therms produced and sold in the second quarter of this year. Notes third quarter production equates to an average of 2.6 million therms per month, up from 2.3 million therms per month in the second quarter, and against hedged volumes of 1.5 million therms per month for the third quarter, down from 1.75 million therms per month for the second quarter. Operational efficiency was 90% for the third quarter compared to 88% operational efficiency for the second quarter. The quarter included a planned full plant shut down for four days at the end of August for safety-critical maintenance and remedial work on one of the two compressor engines on the Saltfleetby site. Further, states work on the previously announced global refinance of the company's debt is well advanced, with a new reservoir model and production forecasts in the process of being finalized for lenders.
----------
Alkemy Capital Investments PLC - London-based company focused on acquisitions in the mining and technology metals sectors - Says Tees Valley Lithium has been shortlisted by a major automotive original equipment manufacturer as the preferred European lithium refiner for a portion of its lithium supply chain after extensive due diligence. Explains Tees Valley is a wholly owned UK subsidiary. Explains the due diligence focussed on Tees Valley Lithium's ability to import a lithium sulphate from its Port Hedland facility in Western Australia and the conversion into battery grade lithium hydroxide or carbonate at an internationally competitive price. Discussions are also advancing well with third parties, including other automotive OEMs, for access to Tees Valley Lithium's multi-train facilities, company states. Further, discussions are ongoing with two major trading groups to supply technical grade carbonate from South America and elsewhere to feed directly one of the trains at Tees Valley Lithium's Wilton refinery to produce battery grade lithium products on a toll treatment basis.
----------
City of London Investment Group PLC - investor in London-listed equities - Confirms Barry Aling will be retiring as non-executive chair at the annual general meeting on October 23. Says Rian Dartnell, a current non-executive director will become chair. Further, says Ted Sevick has been promoted to chief operating officer.
----------
Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Confirms retail offer, launched on September 28, raised GBP118,337 taking total of fundraise to GBP5.1 million. The retail offer will result in the issue of a total of around 1.5 million shares.
----------
